Desmopressin

Aka: Desmopressin, dDAVP, Synthetic Hormone Arginine Vasopressin, Synthetic Vasopressin, Noctiva

advertisement

II. Indications

  1. Diabetes Insipidus
  2. Control of Hemophilia A related bleeding
  3. Primary Nocturnal Enuresis
  4. Nocturia (non-medication options are preferred)
  5. Von Willebrand's Disease
    1. Type I (and in Type 2N) cases prior to surgery and in cases of Trauma
    2. Other VWD forms (Type 2, Type 3 and pseudo-VWF) will not respond to DDAVP
      1. May have paradoxical lowering of VWF

III. Contraindications

  1. Hyponatremia
  2. eGFR <50 ml/min
  3. Conditions predisposing to Hyponatremia
    1. See Drug Interactions below (e.g. Diuretics, steroids, SSRI, NSAIDS)
    2. Caution in age >65 years (higher risk for Hyponatremia)
    3. Impaired Renal Function
    4. Congestive Heart Failure
    5. Polydipsia

IV. Mechanism

  1. Synthetic ADH replacement Hormone (analogue of Vasopressin)
  2. Potent antidiuretic
  3. No Vasopressor activity
  4. Urine Volume decreases by resorbing water at distal renal tubules
  5. Increases release of Von Willebrand FactorProtein (stored in Weibel-Palade bodies)

V. Pharmacokinetics

  1. Duration of action: 12 hours

VI. Precautions

  1. Limit fluid intake for at least 8 hours overnight (when used for Nocturnal Enuresis, Nocturia)
  2. Avoid drinking water before bed (and avoid overnight water ingestion)
  3. Educate patients on symptoms of Hyponatremia (esp. age >65 years)
    1. Nausea or Vomiting
    2. Neurologic symptoms (Headache, confusion, lethargy, Seizures)

VII. Dosing: Nocturnal Enuresis

  1. General
    1. If effective, may continue for 3-6 months
    2. Maintain dose for 4-6 weeks and then slowly taper off over 6 months
      1. Discontinue slowly (e.g. 10 mcg/month)
      2. Reduces risk of relapse
    3. Consider in combination with Bed-Wetting Alarm or Oxybutynin
  2. Desmopressin Intranasal (standard, high dose)
    1. Not recommended due to risk of Hyponatremia (from Water Intoxication)
    2. Initial: 5 mcg spray each nostril qhs
    3. Increase as needed up to 20 mcg each nostril qhs
  3. Desmopressin Oral
    1. Initial: 0.2 mg orally at bedtime
    2. Use lowest effective dose
    3. Increase as needed to 0.6 mg at bedtime

VIII. Dosing: Nocturia in Adults

  1. General
    1. Lower doses are more effective in women
    2. Other non-medication approaches are preferred for Nocturia (or specific treatments)
  2. Desmopressin Intranasal (Noctiva, low dose)
    1. Each spray delivers 0.83 mcg
    2. Start at 1 spray in each nostril at 30 min before bed
    3. May increase to 1.66 mcg after 1 week if tolerated
    4. Marketed for Nocturia in adults
    5. Expensive: $425/month in 2018
  3. Desmopressin Sublingual Tablet
    1. Women: 25 mcg at 1 hour before bed
    2. Men: 50 mcg at 1 hour before bed
  4. Desmopressin Tablet
    1. Take 50-100 mcg nightly at 1 hour before bed

IX. Dosing: Diabetes Insipidus

  1. Nasal Spray: 10-40 mcg daily (or divided 2-3 times per day)
    1. Intranasal 5 mcg equivalent to 0.1 mg oral
  2. Oral Tablet: 0.05 to 1.2 mg orally daily (or divided 2-3 times daily)
  3. Subcutaneous or IV: 2-4 mcg/day IV/SC divided twice daily

X. Dosing: Von Willebrand Disease or Hemophilia A

  1. IV: 0.3 mcg/kg IV over 15 to 30 minutes
  2. Intranasal concentrated dDAVP (Stimate)
    1. Weight <50kg: 150 mcg intranasally (1 spray in SINGLE nostril)
    2. Weight >50kg: 300 mcg intranasally (1 spray EACH nostril)
  3. Pharmacokinetics specific to VWF release
    1. Onset of action within 30-60 minutes with duration of 6-12 hours
    2. Do not repeat more often than every 24 to 48 hours due to Hyponatremia risk (as well as tachyphylaxis)

XI. Adverse Effects

  1. Nasal irritation or Epistaxis with nasal spray
  2. Behavior changes
    1. Aggressive behavior
    2. Nightmares
  3. Nocturia
    1. Administer at night to reduce Nocturia
  4. Severe Hyponatremia (Water Intoxication)
  5. Seizures (with high dose Desmopressin nasal sprays)
  6. Expensive

XII. Drug Interactions: Increased risk of Hyponatremia

  1. Diuretics
  2. Corticosteroids (inhaled or systemic)
  3. Selective Serotonin Reuptake Inhibitors (SSRI)
  4. Chronic NSAIDs

XIII. Labs: Monitoring

  1. Serum Sodium
    1. Obtain baseline, at 7 days, 30 days and periodically (esp. after dose changes)

XIV. Efficacy: Nocturnal Enuresis

  1. Most effective in over age 8-9 years (60-70% respond)
  2. Also more effective if only a few wet nights and normal Bladder capacity
  3. High relapse rate (>80%); Reduced if slowly tapered - see doing above

XV. References

  1. Deloughery and Orman in Majoewsky (2013) EM:Rap 13(9): 1-4
  2. Getaneh (2025) Am Fam Physician 111(6): 515-23 [PubMed]
  3. Tullus (1999) Acta Paediatr 88:1274-8 [PubMed]
  4. Kruse (2001) BJU Int 88:572-6 [PubMed]
  5. Robson (2007) J Urol 178: 24-30 [PubMed]

Images: Related links to external sites (from Bing)

These images are a random sampling from a Bing search on the term "Desmopressin." Click on the image (or right click) to open the source website in a new browser window. Search Bing for all related images

Cost: Medications

desmopressin (on 12/21/2022 at Medicaid.Gov Survey of pharmacy drug pricing)
DESMOPRESSIN 10 MCG/0.1 ML SPR Generic $7.86 per ml
DESMOPRESSIN ACETATE 0.1 MG TB Generic $0.33 each
DESMOPRESSIN ACETATE 0.2 MG TB Generic $0.42 each
FPNotebook does not benefit financially from showing this medication data or their pharmacy links. This information is provided only to help medical providers and their patients see relative costs. Insurance plans negotiate lower medication prices with suppliers. Prices shown here are out of pocket, non-negotiated rates. See Needy Meds for financial assistance information. GoodRx is another tool for finding lower drug prices.

Related Topics in Pharmacology

advertisement